Functional genomics identifies specific vulnerabilities in PTEN-deficient breast cancer
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1465-542X
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Functional genomics identifies specific vulnerabilities in PTEN-deficient breast cancer ; volume:20 ; number:1 ; day:22 ; month:3 ; year:2018 ; pages:1-16 ; date:12.2018
Breast cancer research ; 20, Heft 1 (22.3.2018), 1-16, 12.2018
- Creator
-
Tang, Yew Chung
- Contributor
-
Ho, Szu-Chi
Tan, Elisabeth
Ng, Alvin Wei Tian
McPherson, John R.
Goh, Germaine Yen Lin
Teh, Bin Tean
Bard, Frederic
Rozen, Steven G.
SpringerLink (Online service)
- DOI
-
10.1186/s13058-018-0949-3
- URN
-
urn:nbn:de:1111-201805267219
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:24 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Tang, Yew Chung
- Ho, Szu-Chi
- Tan, Elisabeth
- Ng, Alvin Wei Tian
- McPherson, John R.
- Goh, Germaine Yen Lin
- Teh, Bin Tean
- Bard, Frederic
- Rozen, Steven G.
- SpringerLink (Online service)
Other Objects (12)
Chemotherapy-induced PTEN-L secretion promotes the selection of PTEN-deficient tumor cells
The biology and molecular vulnerabilities of ATM-deficient cancers
Molecular and functional profiling identifies therapeutically targetable vulnerabilities in plasmablastic lymphoma
Molecular and functional profiling identifies therapeutically targetable vulnerabilities in plasmablastic lymphoma
Functional genomics approaches to elucidate vulnerabilities of intrinsic and acquired chemotherapy resistance
Vulnerabilities
Systematic analysis of RNA-binding proteins identifies targetable therapeutic vulnerabilities in osteosarcoma
Is there a causal link between PTEN deficient tumors and immunosuppressive tumor microenvironment?
Proteogenomic analysis of enriched HGSOC tumor epithelium identifies prognostic signatures and therapeutic vulnerabilities
Genome-scale modeling identifies dynamic metabolic vulnerabilities during the epithelial to mesenchymal transition
Multi-Parametric Drug Screening identifies Vulnerabilities and Combination Treatment Strategies for Neuroblastoma Subtypes
E-cadherin-deficient cells have synthetic lethal vulnerabilities in plasma membrane organisation, dynamics and function
Chemotherapy-induced PTEN-L secretion promotes the selection of PTEN-deficient tumor cells
The biology and molecular vulnerabilities of ATM-deficient cancers
Molecular and functional profiling identifies therapeutically targetable vulnerabilities in plasmablastic lymphoma
Molecular and functional profiling identifies therapeutically targetable vulnerabilities in plasmablastic lymphoma
Functional genomics approaches to elucidate vulnerabilities of intrinsic and acquired chemotherapy resistance
Vulnerabilities
Systematic analysis of RNA-binding proteins identifies targetable therapeutic vulnerabilities in osteosarcoma
Is there a causal link between PTEN deficient tumors and immunosuppressive tumor microenvironment?
Proteogenomic analysis of enriched HGSOC tumor epithelium identifies prognostic signatures and therapeutic vulnerabilities
Genome-scale modeling identifies dynamic metabolic vulnerabilities during the epithelial to mesenchymal transition
Multi-Parametric Drug Screening identifies Vulnerabilities and Combination Treatment Strategies for Neuroblastoma Subtypes
E-cadherin-deficient cells have synthetic lethal vulnerabilities in plasma membrane organisation, dynamics and function
Chemotherapy-induced PTEN-L secretion promotes the selection of PTEN-deficient tumor cells
The biology and molecular vulnerabilities of ATM-deficient cancers
Molecular and functional profiling identifies therapeutically targetable vulnerabilities in plasmablastic lymphoma
Molecular and functional profiling identifies therapeutically targetable vulnerabilities in plasmablastic lymphoma
Functional genomics approaches to elucidate vulnerabilities of intrinsic and acquired chemotherapy resistance
Vulnerabilities
Systematic analysis of RNA-binding proteins identifies targetable therapeutic vulnerabilities in osteosarcoma
Is there a causal link between PTEN deficient tumors and immunosuppressive tumor microenvironment?
Proteogenomic analysis of enriched HGSOC tumor epithelium identifies prognostic signatures and therapeutic vulnerabilities
Genome-scale modeling identifies dynamic metabolic vulnerabilities during the epithelial to mesenchymal transition
Multi-Parametric Drug Screening identifies Vulnerabilities and Combination Treatment Strategies for Neuroblastoma Subtypes